Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided Injection for DeQuervain's
NCT02038634Phase 4Terminated
- Sponsor
- Medical College of Wisconsin
- Start
- Aug 2014
- Primary completion
- Mar 2021
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Medical College of Wisconsin. Primary endpoint: Disabilities of the Arm, Shoulder, and Hand Score at 1 year. Started Aug 2014; status: terminated.
Beyond the preview
Go deeper on NCT02038634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02038634.